Phosphatidylinositol (3,4,5)-trisphosphate stimulates phosphorylation of pleckstrin in human platelets

J Biol Chem. 1995 Sep 29;270(39):22807-10. doi: 10.1074/jbc.270.39.22807.

Abstract

We have reported that platelets exposed to thrombin or thrombin receptor-directed ligand activate phospholipase C and rapidly accumulate phosphatidylinositol (3,4,5)-trisphosphate (PtdIns(3,4,5)P3) and phosphatidylinositol (3,4)-bisphosphate (PtdIns(3,4)P2) as a function of the activation of phosphoinositide (PI) 3-kinases in a GTP-binding protein-dependent manner. In such platelets, serine- and threonine-directed phosphorylation of pleckstrin also occurs and has been attributed to protein kinase C activation. We now report that the phosphorylation of pleckstrin is partially dependent upon PI 3-kinase. Pleckstrin phosphorylation in response to thrombin receptor stimulation is progressively susceptible to inhibition by wortmannin, a potent and specific inhibitor of platelet PI 3-kinases. PI 3-kinase thus seems to play a gradually increasing role in promoting pleckstrin phosphorylation. The IC50 for wortmannin in inhibiting SFLLRN-stimulated 3-phosphorylated phosphoinositide accumulation is 10 nM, and that (i.e. 50% of maximum inhibition) for inhibiting pleckstrin phosphorylation is 15 nM. Synthetic PtdIns(3,4,5)P3, when added to saponin-permeabilized (but not intact) platelets, causes wortmannin-insensitive phosphorylation of pleckstrin. PtdIns(3,4,5)P3 also overcomes the inhibition by wortmannin of thrombin- or guanosine 5'-3-O-(thio)trisphosphate-stimulated pleckstrin phosphorylation. In contrast, PtdIns(4,5)P2 or inositol (1,3,4,5)-tetrakisphosphate are ineffective in these respects. The pattern of phosphorylation of pleckstrin activated by PtdIns(3,4,5)P3 is not distinguishable from that of pleckstrin phosphorylated in intact platelets exposed to protein kinase C-activating beta-phorbol myristate acetate, mimicking diacylglycerol. Activation of protein kinase(s) by PtdIns(3,4,5)P3 thus offers a route for pleckstrin phosphorylation in vivo that is an alternative to activation of phospholipase C-->diacylglycerol-->protein kinase C.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Androstadienes / pharmacology
  • Blood Platelets / drug effects
  • Blood Platelets / metabolism*
  • Blood Proteins / drug effects
  • Blood Proteins / isolation & purification
  • Blood Proteins / metabolism*
  • Enzyme Inhibitors / pharmacology
  • Guanosine 5'-O-(3-Thiotriphosphate) / pharmacology
  • Humans
  • Kinetics
  • Peptide Fragments / chemistry
  • Peptide Fragments / isolation & purification
  • Peptide Fragments / pharmacology
  • Phosphatidylinositol 3-Kinases
  • Phosphatidylinositol Phosphates / pharmacology*
  • Phosphatidylinositols / blood
  • Phosphoproteins / blood
  • Phosphoproteins / isolation & purification
  • Phosphorylation
  • Phosphotransferases (Alcohol Group Acceptor) / antagonists & inhibitors
  • Phosphotransferases (Alcohol Group Acceptor) / blood
  • Protein Kinase C / metabolism
  • Receptors, Thrombin / physiology
  • Wortmannin

Substances

  • Androstadienes
  • Blood Proteins
  • Enzyme Inhibitors
  • Peptide Fragments
  • Phosphatidylinositol Phosphates
  • Phosphatidylinositols
  • Phosphoproteins
  • Receptors, Thrombin
  • phosphatidylinositol 3,4,5-triphosphate
  • platelet protein P47
  • thrombin receptor peptide (42-47)
  • Guanosine 5'-O-(3-Thiotriphosphate)
  • Phosphatidylinositol 3-Kinases
  • Phosphotransferases (Alcohol Group Acceptor)
  • Protein Kinase C
  • Wortmannin